GTX16318
antibody from GeneTex
Targeting: NR3C1
GR, GRL
Antibody data
- Antibody Data
- Antigen structure
- References [0]
- Comments [0]
- Validations
- Immunocytochemistry [3]
- Immunohistochemistry [3]
Submit
Validation data
Reference
Comment
Report error
- Product number
- GTX16318 - Provider product page
- Provider
- GeneTex
- Product name
- Glucocorticoid Receptor alpha antibody
- Antibody type
- Polyclonal
- Reactivity
- Human, Mouse, Rat, Sheep
- Host
- Rabbit
No comments: Submit comment
Supportive validation
- Submitted by
- GeneTex (provider)
- Main image
- Experimental details
- ICC/IF analysis of A2058 cells using Glucocorticoid Receptor alpha antibody at a dilution of 1:200 (green). F-Actin staining with Phalloidin (red) and nuclei with DAPI (blue) is shown. Images were taken at 60X magnification.
- Submitted by
- GeneTex (provider)
- Main image
- Experimental details
- ICC/IF analysis of HeLa cells using Glucocorticoid Receptor alpha antibody at a dilution of 1:100 (green). F-Actin staining with Phalloidin (red) and nuclei with DAPI (blue) is shown. Images were taken at 60X magnification.
- Submitted by
- GeneTex (provider)
- Main image
- Experimental details
- ICC/IF analysis of U251 cells using Glucocorticoid Receptor alpha antibody at a dilution of 1:100 (green). F-Actin staining with Phalloidin (red) and nuclei with DAPI (blue) is shown. Images were taken at 60X magnification.
Supportive validation
- Submitted by
- GeneTex (provider)
- Main image
- Experimental details
- IHC-P analysis of human cervical carcinoma with Glucocorticoid Receptor alpha antibody at a dilution of 1:20 (left) or without primary antibody (right).
- Submitted by
- GeneTex (provider)
- Main image
- Experimental details
- IHC-P analysis of human heart tissue with Glucocorticoid Receptor alpha antibody at a dilution of 1:100 (left) or without primary antibody (right).
- Submitted by
- GeneTex (provider)
- Main image
- Experimental details
- IHC-P analysis of human tonsil tissue with Glucocorticoid Receptor alpha antibody at a dilution of 1:50 (left) or without primary antibody (right).